1. Bayliss WM，Starling EH. The mechanism of pancreastic secretion. J Physiol，1902，28（5）：325-353.

2. Moore B，Edie ES，Abram JH. Further observations on the treatment of diabetes mellitus by acid extract of duodenal mucous membrane. Biochem J，1906，1（8-9）：446-454.

3. Cho YM，Kieffer J. K-cells and glucose-dependent insulinotropic polypeptide in health and disease. Vitam Horm，2010，84：111-150.

4. 顿新鹏，陈正望. 肠促胰岛素研究进展.中华糖尿病杂志. 2005，13（4）：316-318.

5. McIntyre N，Holdsworth CD，Turner DS. New interpretation of oral glucose tolerance. Lancet，1964，2：20-21.

6. Unger RH，Eisentraut AM. Entero-insular axis. Arch Intern Med，1969，123：261-266.

7. Creutzfeldt W. The incretin concept today. Diabetologia，1979，16：75-85.

8. Nauck MA，Homberger E，Siegel EG，et al. Incretin effects of increasing glucose loads in man calculated from venous insulin and C-peptide responses. J Clin Endocrinol Metab，1986，63：492-498.

9. Kieffer TJ，Habener JF. The glucagon-like peptides. Endocr Rev，1999，20：876-913.

10. La Barre J，Still EU. Studies on the physiology of secretin：Ⅲ.Further Studies on the Effects of Secrech on the blood Sugar. Am J Physiol，1930，91：649-653.

11. Lund PK，Goodman RH，Dee PC，Habener JF. Pancreatic preproglucagon cDNA contains two glucagon-related coding sequences arranged in tandem. Proc Natl Acad Sci USA，1982，79：345-349.